Overview
Takehiro Yajima practices practicing medicine in Sapporo, Japan.
Their clinical expertise encompasses Parainfluenza, Pneumonia, Squamous Cell Lung Carcinoma, and Lung Cancer.
They are actively involved in clinical research, co-authoring 34 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takehiro Yajima
Is Takehiro Yajima a top-rated expert for Parainfluenza?
MediFind is an objective health platform that identifies experts based on real-world data. Takehiro Yajima is classified as an Experienced expert for Parainfluenza, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takehiro Yajima participate in research or clinical trials?
Yes. Takehiro Yajima has published 34 articles and abstracts on conditions like Parainfluenza. You can view a list of Takehiro Yajima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerYajima isExperienced. Learn about Lung Cancer.
- ParainfluenzaYajima isExperienced. Learn about Parainfluenza.
- PneumoniaYajima isExperienced. Learn about Pneumonia.
- Squamous Cell Lung CarcinomaYajima isExperienced. Learn about Squamous Cell Lung Carcinoma.